The role of side chains in the interaction of new antitumor pyrimidoacridinetriones with DNA: Molecular dynamics simulations

Acta Biochimica Polonica

Volumn 47, Issue 1, 2000, Pages 47-57

  Mazerski, Jan ^a   Antonini, Ippolito ^b   Martelli, Sante ^b  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Molecular dynamics simulations; Pyrimidoacridinetrione antitumor agents; Role of side chain(s); Structure of intercalation complex

Indexed keywords

ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; DNA; PYRIMIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEOTIDE SEQUENCE;

ACRIDINES; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DNA; MOLECULAR STRUCTURE; PYRIMIDINES;

EID: 0033655687     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_4061     Document Type: Article

References (34)

1. Cheng, C.C. & Zee-Cheng, R.K.Y. (1983) The design, synthesis, and development of a new class of potential antineoplastic anthraquinones; in Progress in Medicinal Chemistry (Ellis, G.P. & West, G.B., eds.) pp. 83-118 and references cited therein, Elsevier, Amsterdam.
2. Zee-Cheng, R.K.Y. & Cheng, C.C. (1978) Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkyloamino)anthraquinones. J. Med. Chem. 21, 291-294.
3. Zee-Cheng, R.K.Y., Podrebarac, E.G., Menon, C.S. & Cheng, C.C. (1979) Structural modification study of bis(substituted aminoalkyloamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity. J. Med. Chem. 22, 501-505.
4. Murdock, K.C., Child, R.G., Fabio, P.F., Angier, R.B., Wallace, R.E., Durr, F.E. & Citarella, R.V. (1979) Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]9,10-anthracenediones. J. Med. Chem. 22, 1024-1030.
5. Durr, F.E. (1988) Biochemical pharmacology and tumor biology of mitoxantrone and ametantrone; in Anthracycline and Anthracenedione-Based Anticancer Agents (Lown, J.W., ed.) pp. 401-445, Elsevier, Amsterdam.
6. Cain, B.F. & Atwell, G.J. (1974) The experimental antitumor properties of three congeners of the acridinyl methanesulphonanilide (AMSA) series. Eur. J. Cancer 10, 539-549.
7. Denny, W.A., Baguley, B.C., Cain, B.F. & Waring, M.J. (1983) Antitumor acridines; in Molecular Aspects of Anticancer Drug Action (Neidle, S. & Waring, M.J., eds.) pp. 1-34, Verlag Chemie, Basel.
8. Showalter, H.D.H., Johnson, J.L., Werbel, L.M., Leopold, W.R., Jackson, R.C. & Elslager, E.F. (1984) 5-[(Aminoalkyl)amino]-substituted anthra-[1,9-cd]-pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation. J. Med. Chem. 27, 253-255.
9. Leopold, W.R., Nelson, J.M., Plowman, J. & Jackson, R.C. (1985) Anthrapyrazoles. A new class of intercalating agents with high level, broad spectrum activity against murine tumors. Cancer Res. 45, 5532-5539.
10. Capps, D.B., Dunbar, J., Kesten, S.R., Shillis, J., Werbel, L.M., Plowman, J. & Ward, D.L. (1992) 2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines. A new class of anticancer agents. J. Med. Chem. 35, 4770-4778.
11. LoRusso, P., Wozniak, J., Polin, L., Capps, D., Leopold, W.R., Werbel, L.M., Biernat, L., Dan, M.E. & Corbett, T.H. (1990) Antitumor efficacy of PD 115934 (NSC 366140) against solid tumors of mice. Cancer Res. 60, 4900-4905.
12. Showalter, H.D.H., Angelo, M.M., Berman, E.M., Kanter, G.D., Ortwine, D.F., Ross-Kesten, S.G., Turner, W.R., Werbel, L.M., Worth, D.F., Elslager, E.F., Leopold, W.R. & Shillis, J.L. (1988) Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias. J. Med. Chem. 31, 1527-1539.
13. Atwell, G.J., Rewcastle, G.W., Baguley, B.C. & Denny, W.A. (1987) Potential antitumor agents. 50. In vivo solid-tumor activity of derivatived of N-[2-(diethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem. 30, 664-669.
14. Wakelin, L.P.G., Atwell, G.J., Rewcastle, G.W. & Denny, W.A. (1987) Relationship between DNA-binding kinetics and biological ac-tivity for the 9-aminoacridine-4-carboxamide class of antitumor agents. J. Med. Chem. 30, 855-861.
15. Cholody, W.M., Martelli, S., Paradziej-Lukowicz, J. & Konopa, J. (1990) 5-[(Aminoalkyl)-amino]imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity. J. Med. Chem. 33, 49-52.
16. Cholody, W.M., Martelli, S. & Konopa, J. (1992) Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias. J. Med. Chem. 35, 378-382.
17. Cholody, W.M., Martelli, S. & Konopa, J. (1990) 8-Substituted 5-[(aminoalkylamino]-6H-triazolo[4,5,1-de]acridin-6-ones as potential antineoplastic agents. Synthesis and biological activity. J. Med. Chem. 33, 2582-2586.
18. Antonini, I. & Martelli, S. (1992) The synthesis of a new polycyclic heterocyclic ring system: Pyrimido[5,6,1-de]acridine. J. Heterocyclic Chem. 29, 471-473.
19. Antonini, I., Cola, D., Martelli, S., Cholody, W.M. & Konopa, J. (1992) Pyrimidoacridine derivatives as potential antitumor agents. Il Farmaco, Ed. Sci. 47, 1035-1046.
20. Antonini, I., Cola, D., Polucci, P., Bontemps-Gracz, M., Borowski, E. & Martelli, S. (1995) Synthesis and biological evaluation of dialkylaminoalkyl disubstituted pyrimidoacridinetriones, a novel group of antitumor, resistance reversing agents. J. Med. Chem. 38, 3282-3286.
21. Denny, W.A. (1989) DNA-Intercalating ligands as anticancer drugs: Prospects for future design. Anti-Cancer Drug Des. 4, 241-263.
22. Baguley, B.C. (1991) DNA Intercalating antitumor agents. Anti-Cancer Drug Des. 6, 1-35.
23. Baginski, M., Polucci, P., Antonini, I., Borowski, E. & Martelli, S. (1999) Binding free energy of selected anticancer compounds to DNA - theoretical calculations. Biophys. Chem. (in press).
24. Levitt, M. (1982) Computer simulations of DNA double helix dynamics. Cold Spring Harbor Symposia on Quant. Biol. XLVII, 251-262.
25. Cieplak, P., Rao, S.N., Grootenhuis, P.D.J. & Kollman, P.A. (1990) Free energy calculations on base specificity of drug-DNA interactions: Application to daunomycin and acridine intercalation into DNA.Biopolymers 29, 717-727.
26. 2 complex. J. Biomol. Struct. Dyn. 6, 929-969.
27. Langley, D.R., Doyle, T.W. & Beveridge, D.L. (1991) The dyneimicin-DNA intercalation complex. A model based on DNA affinity cleavage and molecular dynamics simulations. J. Am. Chem. Soc. 113, 4395-4403.
28. Boehncke, M., Nonella, M., Schulten, K. & Wang, A.H.-J. (1991) Molecular dynamics investigation of the interaction between DNA and dystamycin. Biochemistry 30, 5465-5474.
29. Herzyk, P., Neidle, S. & Goodfellow, J.M. (1992) Conformation and dynamics of drug-DNA intercalation. J. Biomol. Struct. Dyn. 10, 97-139.
30. Mazerski, J., Martelli, S. & Borowski, E. (1998) The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: Molecular dynamics simulations. Acta Biochim. Polon. 45, 1-11.
31. Mazerski, J. & Muchewicz, K. (1999) The intercalation of imidazoacridinones into DNA induces conformational changes in their side chain. Acta Biochim. Polon. 47, 65-78.
32. VanGusteren, W.F., Billeter, S.R., Eising, A.A., Hunenberger, P.H., Kruger, P., Mark, E.A., Scott, W.R.P. & Tiron, I.G. (1996) Biomolecular simulation: GROMOS96 manual and user guide. vdf Hochschulverlag AG, Zurich.
33. Ryckeart, J.P., Ciccotti, G. & Berendsen, J.H.C. (1977) Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327-341.
34. Subraminian, P.S., Ravishanker, G. & Beveridge, D.L. (1991) Molecular dynamics of B-DNA including water and counterions. A 140-ps trajectory for d(CGCGAATTCGCG) based on the GROMOS force field. J. Am. Chem. Soc. 113, 5027-5040.